Medtronic Targets Most-Performed Weight-Loss Surgery With 3-In-1 GastriSail
This article was originally published in The Gray Sheet
The company says its new gastric positioning system will speed-up and improve sleeve gastrectomy, which has surged in recent years as the most commonly performed weight-loss procedure.
You may also be interested in...
Nearly half of the world’s adult population will be overweight or obese by 2030 and obesity is tied to more than 40 diseases. Enterprising companies are heeding the call with increasingly less invasive weight loss devices, while an amenable regulatory environment means the marketplace will welcome some of these innovations in 2015.
Dispatches from a world turned upside down include FDA expressing confidence in Chinese manufacturers – to make their GDUFA payments; projections of drug shortages for ventilator patients; and the launch of new hydroxychloroquine studies.
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.